Center-Authored Papers

Filters: Author is Gooley, Theodore A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
No Keywords
Walter RB, Gooley TA, Wood BL, Milano F, Fang M, Sorror ML, Estey EH, Salter AI, Lansverk E, Chien JW et al..  2011.  Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(9):1190-7. Abstract
2008
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell SM, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF et al..  2008.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(6):641-50. Abstract
Rezvani AR, Norasetthada L, Gooley TA, Sorror ML, Bouvier ME, Sahebi F, Agura E, Chauncey TR, Maziarz RT, Maris M et al..  2008.  Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.. British journal of haematology. 143(3):395-403. Abstract
Lupu M, Gooley TA, Zellmer E, Graves SS, Storb R.  2008.  Principles of peripheral blood mononuclear cell apheresis in a preclinical canine model of hematopoietic cell transplantation.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 22(1):74-82. Abstract
Gopal AK, Metcalfe TL, Gooley TA, Pagel JM, Petersdorf SH, Bensinger WI, Holmberg L, Maloney DG, Press OW.  2008.  High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.. Cancer. 113(6):1344-50. Abstract
Till BG, Gooley TA, Crawford N, Gopal AK, Maloney DG, Petersdorf SH, Pagel JM, Holmberg L, Bensinger WI, Press OW.  2008.  Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.. Leukemia & lymphoma. 49(6):1062-73. Abstract
Storer BE, Gooley TA, Jones MP.  2008.  Adjusted estimates for time-to-event endpoints.. Lifetime data analysis. 14(4):484-95. Abstract
Rajendran JG, Gopal AK, Fisher DR, Durack LD, Gooley TA, Press OW.  2008.  Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 49(5):837-44. Abstract
Zaucha R, Gooley TA, Holmberg L, Gopal AK, Press OW, Maloney DG, Bensinger WI.  2008.  High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.. Leukemia & lymphoma. 49(10):1899-906. Abstract
2009
Oehler VG, Guthrie KA, Cummings CL, Sabo K, Wood BL, Gooley TA, Yang T, Epping MT, Shou Y, Pogosova-Agadjanyan E et al..  2009.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.. Blood. 114(15):3299-308. Abstract
Pagel JM, Orgun N, Hamlin DK, Wilbur SD, Gooley TA, Gopal AK, Park SI, Green DJ, Lin Y, Press OW.  2009.  A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.. Blood. 113(20):4903-13. Abstract
Pagel JM, Gooley TA, Rajendran J, Fisher DR, Wilson WA, Sandmaier BM, Matthews DC, Deeg HJ, Gopal AK, Martin PJ et al..  2009.  Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.. Blood. 114(27):5444-53. Abstract
Marcondes AM, Bair S, Rabinovitch PS, Gooley TA, Deeg HJ, Risques R.  2009.  No telomere shortening in marrow stroma from patients with MDS.. Annals of hematology. 88(7):623-8. Abstract
Dai Z, Turtle CJ, Booth GC, Riddell SR, Gooley TA, Stevens AM, Spies T, Groh V.  2009.  Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.. The Journal of experimental medicine. 206(4):793-805. Abstract
Baron F, Petersdorf EW, Gooley TA, Sandmaier BM, Malkki M, Chauncey TR, Maloney DG, Storb R.  2009.  What is the role for donor natural killer cells after nonmyeloablative conditioning? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(5):580-8. Abstract
Hammer MJ, Casper C, Gooley TA, O'Donnell PV, Boeckh MJ, Hirsch IB.  2009.  The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(3):344-51. Abstract
Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA et al..  2009.  Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(28):4685-92. Abstract
2010
Wundes A, Kraft GH, Bowen JD, Gooley TA, Nash RA.  2010.  Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting.. Clinical neurology and neurosurgery. 112(10):876-82. Abstract
Newell LF, Gooley TA, Hansen JA, Stirewalt DL, Petersdorf EW, Deeg HJ.  2010.  Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(12):1700-6. Abstract
Gooley TA, Chien JW, Pergam SA, Hingorani SR, Sorror ML, Boeckh MJ, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR et al..  2010.  Reduced mortality after allogeneic hematopoietic-cell transplantation.. The New England journal of medicine. 363(22):2091-101. Abstract
Gopal AK, Press OW, Shustov AR, Petersdorf SH, Gooley TA, Daniels JT, Garrison MA, Gjerset GF, Lonergan M, Murphy AE et al..  2010.  Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.. Leukemia & lymphoma. 51(8):1523-9. Abstract
Thakar MS, Santos EB, Gooley TA, Sale GE, Storb R, Kiem H-P, Sandmaier BM.  2010.  Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.. Transplantation. 90(1):14-22. Abstract
Walter RB, Pagel JM, Gooley TA, Petersdorf EW, Sorror ML, Woolfrey AE, Hansen JA, Salter AI, Lansverk E, Stewart FM et al..  2010.  Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 24(7):1276-82. Abstract
Chien JW, Sakai M, Gooley TA, Schoch HG, McDonald GB.  2010.  Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials.. Bone marrow transplantation. 45(2):317-24. Abstract
Brunstein CG, Gutman JA, Weisdorf DJ, Woolfrey AE, Defor TE, Gooley TA, Verneris MR, Appelbaum FR, Wagner JE, Delaney C.  2010.  Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.. Blood. 116(22):4693-9. Abstract